Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Anthony ManciniChief Global Commercialization Officer | -3,12k | 375,68k | Derivative Exercise and Sale | 33,62 - 154,82 | 54,40k | - |
| 2026-04-27 | Mr. Anthony ManciniChief Global Commercialization Officer | -3,12k | 308,23k | Derivative Exercise and Sale | 33,62 - 134,34 | 54,40k | - |
| 2026-04-15 | Dr. Mark A. GoldsmithCEO, President & Chairman | -120,00k | 17,46M | Derivative Exercise and Sale | 4,09 - 150,09 | 798,46k | - |
| 2026-03-25 | Mr. Anthony ManciniChief Global Commercialization Officer | -37,45k | 2,32M | Derivative Exercise and Sale | 33,62 - 97,21 | 54,40k | - |
| 2026-03-17 | Dr. Wei LinChief Medical Officer | -2,07k | 206,22k | Automatic Disposition | 99,48 | 39,32k | -5,01% |
| 2026-03-17 | Dr. Stephen M. KelseyPresident of Research & Development | -4,30k | 427,96k | Automatic Disposition | 99,48 | 211,15k | -2,00% |
| 2026-03-17 | Dr. Mark A. GoldsmithCEO, President & Chairman | -12,87k | 1,28M | Automatic Disposition | 99,48 | 798,46k | -1,59% |
| 2026-03-17 | Ms. Margaret A. HornCOO | -4,58k | 455,92k | Automatic Disposition | 99,48 | 84,52k | -5,14% |
| 2026-03-17 | Mr. Jack AndersCFO | -2,75k | 273,87k | Automatic Disposition | 99,48 | 68,91k | -3,84% |
| 2026-03-17 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -2,96k | 291,89k | Automatic Disposition | 97,44 - 99,48 | 10,39k | -22,16% |
| 2026-03-17 | Ms. Xiaolin WangExec. VP of Development | -2,01k | 199,96k | Automatic Disposition | 99,48 | 67,36k | -2,90% |
| 2026-03-04 | Ms. Elizabeth McKee AndersonIndependent Director | -15,00k | 0,00 | Other Disposition | - | 47,06k | -24,17% |
| 2026-03-02 | Dr. Mark A. GoldsmithCEO, President & Chairman | -30,00k | 2,91M | Derivative Exercise and Sale | 4,09 - 102,20 | 786,61k | - |
| 2026-03-02 | Dr. Mark A. GoldsmithCEO, President & Chairman | -6,00k | 607,78k | Verkauf | 98,29 - 102,08 | 786,61k | -0,76% |
| 2026-02-06 | Dr. Mark A. GoldsmithCEO, President & Chairman | 24,01k | 12,97k | Derivative Exercise and Retained Stock | 0,54 | 792,61k | 3,12% |
| 2026-01-21 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -908,00 | 104,96k | Automatic Disposition | 115,60 | 8,21k | -9,96% |
| 2026-01-07 | Ms. Margaret A. HornCOO | -75,00k | 4,66M | Derivative Exercise and Sale | 29,80 - 102,90 | 79,83k | - |
| 2026-01-07 | Mr. Jack AndersCFO | -10,00k | 555,50k | Derivative Exercise and Sale | 42,45 - 98,00 | 65,73k | - |
| 2025-12-16 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -2,69k | 206,48k | Automatic Disposition | 76,82 | 9,12k | -22,77% |
| 2025-12-16 | Dr. Stephen M. KelseyPresident of Research & Development | -5,45k | 418,42k | Automatic Disposition | 76,82 | 205,02k | -2,59% |
| 2025-12-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -15,39k | 1,18M | Automatic Disposition | 76,82 | 768,60k | -1,96% |
| 2025-12-16 | Ms. Margaret A. HornCOO | -4,85k | 372,33k | Automatic Disposition | 76,82 | 79,83k | -5,72% |
| 2025-12-16 | Mr. Jack AndersCFO | -3,10k | 239,29k | Automatic Disposition | 77,09 | 65,73k | -4,51% |
| 2025-11-25 | Dr. Mark A. GoldsmithCEO, President & Chairman | -60,00k | 4,26M | Derivative Exercise and Sale | 4,09 - 75,08 | 759,29k | - |
| 2025-11-25 | Dr. Mark A. GoldsmithCEO, President & Chairman | -6,00k | 450,00k | Verkauf | 75,00 | 759,29k | -0,78% |
| 2025-11-25 | Mr. Jack AndersCFO | -5,42k | 308,83k | Derivative Exercise and Sale | 17,00 - 74,00 | 62,72k | - |
| 2025-11-18 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -13,39k | 370,69k | Derivative Exercise and Sale | 42,45 - 70,14 | 6,52k | - |
| 2025-11-18 | Dr. Mark A. GoldsmithCEO, President & Chairman | -20,00k | 1,33M | Derivative Exercise and Sale | 4,09 - 70,38 | 765,29k | - |
| 2025-11-12 | Dr. Mark A. GoldsmithCEO, President & Chairman | -20,00k | 1,22M | Derivative Exercise and Sale | 4,09 - 65,07 | 765,29k | - |
| 2025-11-11 | Mr. Jack AndersCFO | -10,00k | 470,00k | Derivative Exercise and Sale | 17,00 - 64,00 | 62,72k | - |
| 2025-11-07 | Dr. Mark A. GoldsmithCEO, President & Chairman | -30,00k | 1,77M | Derivative Exercise and Sale | 1,12 - 60,31 | 765,29k | - |
| 2025-11-12 | Dr. Mark A. GoldsmithCEO, President & Chairman | -100,00k | 0,00 | Other Disposition | - | 765,29k | -11,56% |
| 2025-10-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -20,00k | 1,03M | Derivative Exercise and Sale | 1,12 - 55,00 | 765,29k | - |
| 2025-10-17 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -12,00k | 221,16k | Derivative Exercise and Sale | 36,57 - 55,00 | 6,52k | - |
| 2025-10-13 | Dr. Stephen M. KelseyPresident of Research & Development | -25,00k | 1,10M | Derivative Exercise and Sale | 4,73 - 48,54 | 200,05k | - |
| 2025-09-24 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1,80k | 79,62k | Automatic Disposition | 44,26 | 6,52k | -21,64% |
| 2025-09-16 | Dr. Wei LinChief Medical Officer | -2,16k | 98,98k | Automatic Disposition | 45,82 | 29,49k | -6,82% |
| 2025-09-16 | Dr. Stephen M. KelseyPresident of Research & Development | -5,37k | 245,94k | Automatic Disposition | 45,82 | 200,05k | -2,61% |
| 2025-09-16 | Ms. Margaret A. HornCOO | -4,78k | 218,81k | Automatic Disposition | 45,82 | 75,40k | -5,96% |
| 2025-09-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -13,41k | 614,56k | Automatic Disposition | 45,82 | 765,29k | -1,72% |
| 2025-09-16 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1,87k | 85,65k | Automatic Disposition | 45,82 | 8,31k | -18,35% |
| 2025-09-16 | Mr. Jack AndersCFO | -2,32k | 106,31k | Automatic Disposition | 45,82 | 62,72k | -3,57% |
| 2025-09-11 | Dr. Stephen M. KelseyPresident of Research & Development | -125,00k | 4,97M | Derivative Exercise and Sale | 4,73 - 46,93 | 194,99k | - |
| 2025-09-02 | Mr. Jack AndersCFO | -10,00k | 334,32k | Derivative Exercise and Sale | 2,68 - 40,17 | 59,10k | - |
| 2025-06-30 | Dr. Mark A. GoldsmithCEO, President & Chairman | 37,00k | 19,98k | Derivative Exercise and Retained Stock | 0,54 | 753,98k | 5,16% |
| 2025-06-20 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1,91k | 75,74k | Automatic Disposition | 39,61 | 5,04k | -27,51% |
| 2025-06-16 | Dr. Mark A. GoldsmithCEO, President & Chairman | -13,50k | 537,55k | Automatic Disposition | 39,83 | 716,98k | -1,85% |
| 2025-06-16 | Ms. Margaret A. HornCOO | -3,51k | 139,80k | Automatic Disposition | 39,83 | 70,90k | -4,72% |
| 2025-06-16 | Mr. Jack AndersCFO | -2,17k | 86,43k | Automatic Disposition | 39,83 | 59,10k | -3,54% |
| 2025-06-16 | Mr. Jeffrey CisliniSenior VP, General Counsel & Corporate Secretary | -1,88k | 74,80k | Automatic Disposition | 39,83 | 6,95k | -21,27% |
| 2025-06-16 | Dr. Wei LinChief Medical Officer | -2,17k | 86,55k | Automatic Disposition | 39,83 | 25,70k | -7,80% |
| 2025-06-16 | Dr. Stephen M. KelseyPresident of Research & Development | -4,29k | 170,83k | Automatic Disposition | 39,83 | 194,99k | -2,15% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
